Research map: Systemic Bevacizumab for Severe Bleeding From Acquired Gastrointestinal Vascular Malformations

Back to the article

Papers in this map

  1. Second International Guidelines for the Diagnosis and Management of Hereditary Hemorrhagic Telangiectasia · Marie E. Faughnan · 2020 · 540 citations · Cited by this paper
  2. Systemic Mastocytosis in Adults: 2026 Update on Diagnosis, Risk Stratification and Management · 2026 · Related
  3. Angiogenesis in chronic liver disease and its complications · Stéphanie Coulon · 2010 · 280 citations · Cited by this paper
  4. Treatment Patterns and Clinical Outcomes After Immunotherapy Failure in Patients With Natural Killer/T‐Cell Lymphoma · 2026 · Related
  5. An international, multicenter study of intravenous bevacizumab for bleeding in hereditary hemorrhagic telangiectasia: the InHIBIT-Bleed study · Hanny T. Al-Samkari · 2020 · 158 citations · Cited by this paper
  6. Dasatinib Exposure and Risk of CMV Reactivation in Philadelphia Chromosome‐Positive Acute Lymphoblastic Leukemia · 2026 · Related
  7. Hereditary hemorrhagic telangiectasia: systemic therapies, guidelines, and an evolving standard of care · Hanny T. Al-Samkari · 2020 · 84 citations · Cited by this paper
  8. Intensive Induction in AML in the Era of Venetoclax: A Standing Count for “7 + 3”? · 2026 · Related
  9. Gastrointestinal Angiodysplasia · Christian S. Jackson · 2016 · 72 citations · Cited by this paper
  10. ICC / WHO ‐Defined and NGS ‐Annotated Idiopathic Hypereosinophilia ( iHES / iHE ): Mutations, Clinical and Treatment Details, and Predictors of Survival · 2026 · Related
  11. Thalidomide for Recurrent Bleeding Due to Small-Intestinal Angiodysplasia · Huimin Chen · 2023 · 70 citations · Cited by this paper
  12. Promoter TERT ‐ Related Hematopoietic Somatic Mosaicism in Patients With Telomere Biology Disorders · 2026 · Related
  13. Systemic bevacizumab for the treatment of chronic bleeding in hereditary haemorrhagic telangiectasia · Hanny T. Al-Samkari · 2018 · 68 citations · Cited by this paper
  14. Mosaic Chromosomal Alterations Identify Ultra‐High Risk Clonal Hematopoiesis in Patients With Lymphoma Undergoing Intensive Chemotherapy · 2026 · Related
  15. THE IRON CONTENT OF CRYSTALLINE HUMAN HEMOGLOBIN · Finn W. Bernhart · 1943 · 53 citations · Cited by this paper
  16. A New Fetal Hemoglobin‐Related Phenotype in Sickle Cell Anemia · 2026 · Related
  17. Pazopanib for severe bleeding and transfusion-dependent anemia in hereditary hemorrhagic telangiectasia · Joseph G. Parambil · 2021 · 51 citations · Cited by this paper
  18. p53 Immunohistochemistry Is a Reliable Method for Assessing TP53 Allelic and Functional Status in TP53 ‐Mutated Cases · 2026 · Related
  19. Intravenous Bevacizumab Reduces Transfusion Requirements and Endoscopic Interventions in Patients With Gastric Antral Vascular Ectasia and Small Bowel Angioectasia · Hasan Ahmad Hasan Albitar · 2019 · 45 citations · Cited by this paper
  20. Pomalidomide for Epistaxis in Hereditary Hemorrhagic Telangiectasia · Hanny T. Al-Samkari · 2024 · 44 citations · Cited by this paper
  21. Standard of Care Versus Octreotide in Angiodysplasia-Related Bleeding (the OCEAN Study): A Multicenter Randomized Controlled Trial · Lia C. M. J. Goltstein · 2023 · 38 citations · Cited by this paper
  22. An international survey to evaluate systemic bevacizumab for chronic bleeding in hereditary haemorrhagic telangiectasia · Hanny T. Al-Samkari · 2020 · 29 citations · Cited by this paper
  23. How I treat bleeding in hereditary hemorrhagic telangiectasia · Hanny T. Al-Samkari · 2024 · 27 citations · Cited by this paper
  24. An overview of angiodysplasia: management and patient prospects · Grainne E. Holleran · 2018 · 24 citations · Cited by this paper
  25. Intravenous bevacizumab as a novel treatment for refractory left ventricular assist device-related gastrointestinal bleeding · Rabea Asleh · 2020 · 17 citations · Cited by this paper
  26. Systemic bevacizumab for refractory bleeding and transfusion-dependent anemia in Heyde syndrome · Andrew B. Song · 2021 · 17 citations · Cited by this paper
  27. In-hospital weekend outcomes in patients diagnosed with bleeding gastroduodenal angiodysplasia: a population-based study, 2000 to 2011 · Steve Serrao · 2016 · 15 citations · Cited by this paper
  28. Assessment of serum angiogenic factors as a diagnostic aid for small bowel angiodysplasia in patients with obscure gastrointestinal bleeding and anaemia · Grainne E. Holleran · 2017 · 15 citations · Cited by this paper
  29. A hematologic support score for longitudinal measurement of blood and iron requirements in hereditary hemorrhagic telangiectasia and other chronic bleeding disorders · Hanny T. Al-Samkari · 2020 · 14 citations · Cited by this paper
  30. Characterizing the Healthcare Utilization and Costs of Hereditary Hemorrhagic Telangiectasia · Hanny T. Al-Samkari · 2025 · 14 citations · Cited by this paper
  31. Gastrointestinal bleeding from vascular malformations: Is octreotide effective to rescue difficult-to-treat patients? · Andrea Iannone · 2016 · 13 citations · Cited by this paper
  32. Standardization of Terminology, Definitions, and Outcome Criteria for Bleeding in Hereditary Hemorrhagic Telangiectasia: International Consensus Report · Hanny T. Al-Samkari · 2025 · 13 citations · Cited by this paper
  33. Clinical spectrum of hereditary hemorrhagic telangiectasia: data from the Comprehensive HHT Outcomes Registry of the US (CHORUS) · Hanny T. Al-Samkari · 2026 · 12 citations · Cited by this paper
  34. Systemic bevacizumab as salvage therapy for persistent severe bleeding and anemia in heyde syndrome following aortic valve replacement · Zain Mohammad Virk · 2022 · 11 citations · Cited by this paper
  35. Cost-effectiveness of bevacizumab therapy in the care of patients with hereditary hemorrhagic telangiectasia · Daniel Wang · 2024 · 10 citations · Cited by this paper
  36. Epidemiology and risk factors for angiodysplasias of the upper and lower gastrointestinal tract: A large population-based study · Anton Bermont · 2024 · 10 citations · Cited by this paper
  37. Engasertib versus Placebo for Bleeding in Hereditary Hemorrhagic Telangiectasia · Hanny T. Al-Samkari · 2025 · 7 citations · Cited by this paper
  38. Pomalidomide for hereditary hemorrhagic telangiectasia: after trial longitudinal assessment study (PATH-HHT ATLAS) · Ellen Zhang · 2026 · 6 citations · Cited by this paper
  39. Systemic bevacizumab to facilitate anticoagulation in antiphospholipid syndrome and bleeding gastrointestinal angiodysplasia · Abraham Zachary Cheloff · 2021 · 4 citations · Cited by this paper

Source: OpenAlex (CC0)